Pharmacological interventions for sialorrhoea in people with Parkinson's disease: a systematic review and meta-analysis

Naeem, F., Reid, J., Bailey, M., Reid, A., Smyth, C., Taylor-Rowan, M. , Newman, E. J. and Quinn, T. (2023) Pharmacological interventions for sialorrhoea in people with Parkinson's disease: a systematic review and meta-analysis. Movement Disorders Clinical Practice, 10(4), pp. 558-568. (doi: 10.1002/mdc3.13688) (PMID:37070045)

[img] Text
292277.pdf - Accepted Version

423kB

Abstract

Background/objectives: Sialorrhoea is a common non motor complication experienced by people with Parkinson's disease (PD). Despite its prevalence there is conflicting evidence on how to effectively treat it. Our aim was to establish the efficacy and safety outcomes of pharmacological interventions used to treat sialorrhoea in people with idiopathic PD. Methods: We registered and conducted a systematic review and meta-analysis (PROSPERO: CRD42016042470). We searched seven electronic databases from inception until July 2022. Quantitative synthesis was performed where data allowed using random effects models. Results: From 1374 records we included 13 studies (n = 405 participants). Studies were conducted in Europe, North America and China. There was marked heterogeneity in the interventions used, follow up times and outcome measures investigated. The main source of risk of bias identified was reporting bias. Five studies were included in the quantitative synthesis. Summary estimates showed administration of botulinum toxin significantly reduced saliva production, improved patient reported functional outcomes and was associated with an increase in adverse events. Conclusion: Sialorrhoea in PD is an important condition, but current data does not allow for strong recommendations on optimal pharmacological treatments. There is significant heterogeneity in outcomes measures used to evaluate the burden of sialorrhoea with lack of consensus on what constitutes clinically meaningful change. More research is required to better understand the underlying mechanism and potential treatments of sialorrhoea in idiopathic PD.

Item Type:Articles
Keywords:Sialorrhoea, Parkinson’s Disease, Botulinum toxin.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Quinn, Professor Terry and Taylor-Rowan, Dr Martin and Newman, Dr Edward and Naeem, Dr Fariha
Authors: Naeem, F., Reid, J., Bailey, M., Reid, A., Smyth, C., Taylor-Rowan, M., Newman, E. J., and Quinn, T.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > General Practice and Primary Care
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Movement Disorders Clinical Practice
Publisher:Wiley
ISSN:2330-1619
ISSN (Online):2330-1619
Published Online:08 February 2023
Copyright Holders:Copyright © 2023 International Parkinson and Movement Disorder Society
First Published:First published in Movement Disorders Clinical Practice 10(4): 558-568
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record